The fact
Phase 2 clinical trials show promising results in reducing recurrences.
The vaccine could be available within 3 to 5 years if tests confirm its effectiveness.
Click the link to read an article on the topic:
Phase 2 clinical trials show promising results in reducing recurrences.
The vaccine could be available within 3 to 5 years if tests confirm its effectiveness.